Clevidipine Butyrate

Category: Blood Pressure

Clevidipine Butyrate Overview

Clevidipine (INN,[2] trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. It was approved by the United States Food and Drug Administration on August 1, 2008. Contents 1 Basic chemical and pharmacological properties 1.1 Stereochemistry 2 Dosage and administration 3 Safety information 4 Drug interactions 5 Storage 6 Phase III clinical trial results 7 References ...

Read more Clevidipine Butyrate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Clevidipine Butyrate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Clevidipine Butyrate
  • Emulsion: 0.5mg/ml, 125mg/250ml (0.5mg/ml), 25mg/50ml (0.5mg/ml), 25mg/50ml(0.5mg/ml), 50mg/100ml (0.5mg/ml), 50mg/100ml(0.5mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Clevidipine Butyrate or a similar ingredient: (1 result)

Related Clevidipine Butyrate Topics:

Clevidipine Butyrate
unfortuneately, i have no idea what this pill looks like. my son was an addict yrs ago, but has recently aquired this dr...

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 5 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA